Company

NovAccess Global Inc. (0001039466)

Standardized SEC financial data for NovAccess Global Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001039466 · Pharmaceutical Preparations.

Return on equity

26.5%

Free cash flow

-$215K

Debt / equity

-0.02×

Current ratio

0.01×

EPS (diluted)

$-0.06

Ratios for fiscal year 2024, standardized from SEC filings.

Income statement

USD	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$0	$0	—	$0	$0	$0
Cost of revenue	$0	$0	—	$0	$0	$0
Gross profit	$0	$0	—	$0	$0	$0
R&D expense	—	—	$146K

Standardized from NovAccess Global Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.

Balance sheet

USD	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
Cash & equivalents	$8K	$178	$181K	$64K	$21K	$21K
Total current assets	$213K	$178	—	—	$62K	$62K
Property, plant & equipment	$3K	$0	—	—

Cash flow

USD	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
Operating cash flow	$193K	-$261K	-$682K	-$903K	-$625K	-$215K
Capital expenditures	$2K	$0	—	—	—	—
Free cash flow	$190K	-$261K	—	—	—

Get 0001039466 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001039466/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001039466/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0001039466 filings on SEC EDGAR →